QuiaPEG

Newsroom

Se nyheter från:
Page:
123456
June 23, 2018

The shareholders of QuiaPEG Pharmaceuticals Holding AB, org.nr 556658-0196, are hereby given notice to attend the Annual General Meeting to be held on June 29, 2018 10:00 a.m. at MAQS Advokatbyrå, Mäster Samuelsgatan 20 in Stockholm. Registration to the annual general meeting starts at 09:30 a.m.

May 28, 2018

QuiaPEG Pharmaceuticals Holding AB (publ) receives a so-called "Notice of Allowance" regarding granting of a patent in Europe.

Apr 27, 2018

QuiaPEG Pharmaceuticals Holding AB (publ), ”QuiaPEG”,announces today that the company has decided on a directed new issue of shares and subscription warrants to the Dutchinvestment group Nyenburgh Holding B.V., ”NYIP”.

Mar 12, 2018

QuiaPEG Pharmaceuticals Holding AB (publ), ”QuiaPEG”, announces today that, through its subsidiary, the company has entered into a licensing and commercialization agreement with the global Chinese company Xiamen SinoPEG Biotech Ltd, ”SinoPEG”, a key player in the pegylation industry for development , manufacturing, marketing and sales of products and services based on QuiaPEG’s release pegylation technology, Uni-Qleaver®.

Page:
123456
Contact
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
Sweden
+46 (0) 70 693 12 53
info@quiapeg.com

User terms & privacy policy
Send a message